473 related articles for article (PubMed ID: 35982439)
1. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
Bilbao A; Spanagel R
BMC Med; 2022 Aug; 20(1):259. PubMed ID: 35982439
[TBL] [Abstract][Full Text] [Related]
2. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Spanagel R; Bilbao A
Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L
Lancet Psychiatry; 2019 Dec; 6(12):995-1010. PubMed ID: 31672337
[TBL] [Abstract][Full Text] [Related]
5. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M; De Toffol M; Kim JY; Choi MJ; Stubbs B; Thompson T; Firth J; Miola A; Croatto G; Baggio F; Michelon S; Ballan L; Gerdle B; Monaco F; Simonato P; Scocco P; Ricca V; Castellini G; Fornaro M; Murru A; Vieta E; Fusar-Poli P; Barbui C; Ioannidis JPA; Carvalho AF; Radua J; Correll CU; Cortese S; Murray RM; Castle D; Shin JI; Dragioti E
BMJ; 2023 Aug; 382():e072348. PubMed ID: 37648266
[TBL] [Abstract][Full Text] [Related]
6. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
7. [Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
Mücke M; Carter C; Cuhls H; Prüß M; Radbruch L; Häuser W
Schmerz; 2016 Feb; 30(1):25-36. PubMed ID: 26809975
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
9. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
[TBL] [Abstract][Full Text] [Related]
10. Cannabis for the treatment of ulcerative colitis.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
[TBL] [Abstract][Full Text] [Related]
11. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.
Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A
Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.
Allan GM; Finley CR; Ton J; Perry D; Ramji J; Crawford K; Lindblad AJ; Korownyk C; Kolber MR
Can Fam Physician; 2018 Feb; 64(2):e78-e94. PubMed ID: 29449262
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials.
McParland AL; Bhatia A; Matelski J; Tian C; Diep C; Clarke H; Kapustin D; Triveda A; Brull R; Singh M
Reg Anesth Pain Med; 2023 Apr; 48(4):180-190. PubMed ID: 36598058
[TBL] [Abstract][Full Text] [Related]
14. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M
Curr Neurol Neurosci Rep; 2018 Feb; 18(2):8. PubMed ID: 29442178
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
16. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of cannabis and cannabinoids.
Grotenhermen F; Müller-Vahl K
Dtsch Arztebl Int; 2012 Jul; 109(29-30):495-501. PubMed ID: 23008748
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA; Raup-Konsavage WM; Vrana KE
Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
[TBL] [Abstract][Full Text] [Related]
19. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
